Compare ESLA & BCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ESLA | BCG |
|---|---|---|
| Founded | 2021 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.1M | 21.6M |
| IPO Year | 2021 | 2025 |
| Metric | ESLA | BCG |
|---|---|---|
| Price | $0.91 | $1.14 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 3.8M | 12.7K |
| Earning Date | 11-11-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 112.50 |
| EPS | N/A | ★ 0.08 |
| Revenue | N/A | ★ $187,144,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $13.63 |
| Revenue Growth | N/A | ★ 10.80 |
| 52 Week Low | $0.24 | $0.95 |
| 52 Week High | $3.15 | $3.44 |
| Indicator | ESLA | BCG |
|---|---|---|
| Relative Strength Index (RSI) | 69.25 | 47.54 |
| Support Level | $0.70 | $0.95 |
| Resistance Level | $1.31 | $1.65 |
| Average True Range (ATR) | 0.16 | 0.05 |
| MACD | 0.07 | 0.02 |
| Stochastic Oscillator | 74.68 | 70.00 |
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
Binah Capital Group Inc formerly Wentworth Management Services LLC is a holding company that acquires and manages businesses in the wealth management industry. The company specializes in consolidating independent broker-dealers to capture economies of scale needed to service financial advisors in today's technology-enabled regulatory environment. Wentworth's core philosophy focuses on building long-term, productive relationships with its advisor base.